{"id":"https://openalex.org/W2108364254","doi":"https://doi.org/10.1136/bjo.2007.132597","title":"Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial","display_name":"Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial","alternate_titles":[],"publication_year":2008,"publication_date":"2008-07-09","ids":{"openalex":"https://openalex.org/W2108364254","doi":"https://doi.org/10.1136/bjo.2007.132597","mag":"2108364254","pmid":"https://pubmed.ncbi.nlm.nih.gov/18614570","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2584239"},"language":"en","primary_location":{"id":"doi:10.1136/bjo.2007.132597","doi":"https://doi.org/10.1136/bjo.2007.132597","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bjo.2007.132597","pdf_url":"https://bjo.bmj.com/content/bjophthalmol/92/12/1606.full.pdf","source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2108364254"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://bjo.bmj.com/content/bjophthalmol/92/12/1606.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005076098","display_name":"Lawrence J. Singerman","orcid":"https://orcid.org/0000-0002-9048-8358","observed_orcids":["https://orcid.org/0000-0002-9048-8358"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"L J Singerman","raw_affiliation_strings":["Retina Associates of Cleveland, 3401 Enterprise Parkway, Suite 300, Cleveland, OH 44122, USA. lsingerman@retina-assoc.com","Retina Associates of Cleveland, 3401 Enterprise Parkway, Suite 300, Cleveland, OH 44122, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retina Associates of Cleveland, 3401 Enterprise Parkway, Suite 300, Cleveland, OH 44122, USA. lsingerman@retina-assoc.com","institution_ids":[]},{"raw_affiliation_string":"Retina Associates of Cleveland, 3401 Enterprise Parkway, Suite 300, Cleveland, OH 44122, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037783985","display_name":"Harvey Masonson","orcid":"https://orcid.org/0000-0001-5848-7585","observed_orcids":["https://orcid.org/0000-0001-5848-7585"]},"institutions":[{"id":"https://openalex.org/I4210127326","display_name":"Ophthotech (United States)","ror":"https://ror.org/035pepv51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127326"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H Masonson","raw_affiliation_strings":["Ophthotech Corporation, Princeton, New Jersey, USA","Ophthotech Corp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthotech Corporation, Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210127326"]},{"raw_affiliation_string":"Ophthotech Corp","institution_ids":["https://openalex.org/I4210127326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012595548","display_name":"M. Patel","orcid":"https://orcid.org/0009-0002-3266-8841","observed_orcids":["https://orcid.org/0009-0002-3266-8841"]},"institutions":[{"id":"https://openalex.org/I2799870999","display_name":"Connecticut Science Center","ror":"https://ror.org/01qpqce32","country_code":"US","type":"archive","lineage":["https://openalex.org/I2799870999"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Patel","raw_affiliation_strings":["Optherion Inc, New Haven, Connecticut, USA","Optherion Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optherion Inc, New Haven, Connecticut, USA","institution_ids":["https://openalex.org/I2799870999"]},{"raw_affiliation_string":"Optherion Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085600986","display_name":"Anthony P. Adamis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A P Adamis","raw_affiliation_strings":["Jerini Ophthalmic, New York, USA","Jerini Ophthalmics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerini Ophthalmic, New York, USA","institution_ids":[]},{"raw_affiliation_string":"Jerini Ophthalmics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032451162","display_name":"Ronald R. Buggage","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R Buggage","raw_affiliation_strings":["Pfizer, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, New York, New York, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110271174","display_name":"Emmett T. Cunningham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801780550","display_name":"California Pacific Medical Center","ror":"https://ror.org/02bjh0167","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114073160","https://openalex.org/I2801780550"]},{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E Cunningham","raw_affiliation_strings":["California Pacific Medical Center, San Francisco, California, USA","Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA","Stanford University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"California Pacific Medical Center, San Francisco, California, USA","institution_ids":["https://openalex.org/I2801780550"]},{"raw_affiliation_string":"Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"raw_affiliation_string":"Stanford University","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040480758","display_name":"Mauro Goldbaum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Goldbaum","raw_affiliation_strings":["Eyetech Inc, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eyetech Inc, New York, New York, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021178653","display_name":"Barrett Katz","orcid":"https://orcid.org/0000-0003-0953-7675","observed_orcids":["https://orcid.org/0000-0003-0953-7675"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B Katz","raw_affiliation_strings":["Danube Pharmaceutials Inc, New York, New York, USA","Ophthalmology & Visual Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danube Pharmaceutials Inc, New York, New York, USA","institution_ids":[]},{"raw_affiliation_string":"Ophthalmology & Visual Sciences","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"D Guyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D Guyer","raw_affiliation_strings":["SV Life Sciences, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SV Life Sciences, Boston, Massachusetts, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5005076098"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.7611,"has_fulltext":true,"cited_by_count":140,"citation_normalized_percentile":{"value":0.98814597,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"92","issue":"12","first_page":"1606","last_page":"1611"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegaptanib-sodium","display_name":"pegaptanib sodium","score":0.9980000257492065},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.8090000152587891},{"id":"https://openalex.org/keywords/long-term-drug-safety","display_name":"long-term drug safety","score":0.7739999890327454},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.8259999752044678},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.652999997138977},{"id":"https://openalex.org/keywords/ocular-toxicity","display_name":"ocular toxicity","score":0.6050000190734863},{"id":"https://openalex.org/keywords/vision-trial","display_name":"VISION trial","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C2777512022","wikidata":"https://www.wikidata.org/wiki/Q409935","display_name":"Pegaptanib","level":5,"score":0.9892299771308899},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.908715009689331},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.7280581593513489},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5618144869804382},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5202652215957642},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41854000091552734},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3758460581302643},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27923595905303955},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.22304368019104004},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.21727913618087769},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1099330484867096}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005451","descriptor_name":"Fluorescein Angiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007429","descriptor_name":"Intraocular Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014065","descriptor_name":"Tonometry, Ocular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D052157","descriptor_name":"Aptamers, Nucleotide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1136/bjo.2007.132597","doi":"https://doi.org/10.1136/bjo.2007.132597","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bjo.2007.132597","pdf_url":"https://bjo.bmj.com/content/bjophthalmol/92/12/1606.full.pdf","source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2584239","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2584239/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Ophthalmol","raw_type":"Text"},{"id":"pmid:18614570","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18614570","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of ophthalmology","raw_type":"Journal Article"},{"id":"pmh:oai:open-archive.highwire.org:bjophthalmol:92/12/1606","doi":null,"is_oa":false,"landing_page_url":"http://bjo.bmj.com/cgi/content/short/92/12/1606","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:open-archive.highwire.org:bjophthalmol:bjo.2007.132597v1","doi":null,"is_oa":false,"landing_page_url":"http://bjo.bmj.com/cgi/content/short/bjo.2007.132597v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.277.9298","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.277.9298","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/70/de/Br_J_Ophthalmol_2008_Dec_9_92(12)_1606-1611.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1136/bjo.2007.132597","doi":"https://doi.org/10.1136/bjo.2007.132597","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bjo.2007.132597","pdf_url":"https://bjo.bmj.com/content/bjophthalmol/92/12/1606.full.pdf","source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332585","display_name":"Allergan","ror":"https://ror.org/00wthd003"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2108364254.pdf","grobid_xml":"https://content.openalex.org/works/W2108364254.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W39459872","https://openalex.org/W1583699618","https://openalex.org/W1613798522","https://openalex.org/W1802218256","https://openalex.org/W1970488100","https://openalex.org/W1976893749","https://openalex.org/W1987306181","https://openalex.org/W1992257311","https://openalex.org/W1996409623","https://openalex.org/W2024725915","https://openalex.org/W2025388522","https://openalex.org/W2052066839","https://openalex.org/W2059277692","https://openalex.org/W2063709616","https://openalex.org/W2073542665","https://openalex.org/W2076270591","https://openalex.org/W2091534585","https://openalex.org/W2096521047","https://openalex.org/W2098582960","https://openalex.org/W2099927130","https://openalex.org/W2105652693","https://openalex.org/W2121785313","https://openalex.org/W2122595579","https://openalex.org/W2132272301","https://openalex.org/W2143336140","https://openalex.org/W2150893441","https://openalex.org/W2159841299","https://openalex.org/W2171524333","https://openalex.org/W2403486051","https://openalex.org/W2417871216","https://openalex.org/W3010920747","https://openalex.org/W4247616760","https://openalex.org/W6731477274"],"related_works":["https://openalex.org/W2159841299","https://openalex.org/W2417871216","https://openalex.org/W2087372999","https://openalex.org/W2418126227","https://openalex.org/W3023116999","https://openalex.org/W1970248446","https://openalex.org/W2085312730","https://openalex.org/W2002673482","https://openalex.org/W2075604506"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"evaluate":[2],"the":[3,15],"safety":[4,160,194],"of":[5,10,17,37,158,196],"up":[6],"to":[7,39,61,65,117,163,179,188],"3":[8,47,102],"years":[9,94,111,129],"pegaptanib":[11,42,62,87,101,133,189,197],"sodium":[12,43,198],"therapy":[13,69],"in":[14,93,110,128,137,145,170,177,201],"treatment":[16,109],"neovascular":[18],"age-related":[19],"macular":[20],"degeneration":[21],"(NV-AMD).":[22],"METHODS:":[23],"Two":[24],"concurrent,":[25],"prospective,":[26],"multicentre,":[27],"double-masked":[28],"studies":[29],"randomised":[30],"subjects":[31,75,85],"with":[32,203],"all":[33],"angiographic":[34],"lesion":[35],"compositions":[36],"NV-AMD":[38],"receive":[40,108],"intravitreous":[41],"(0.3,":[44],"1":[45,91,95,112,121,130],"and":[46,113,131,149],"mg)":[48],"or":[49,67,79,90,96,104,120,182],"sham":[50],"injections":[51],"every":[52],"6":[53],"weeks":[54],"for":[55,70,123],"54":[56],"weeks.":[57],"Those":[58],"initially":[59],"assigned":[60],"were":[63,115,142,154,174],"rerandomised":[64,116],"continue":[66],"discontinue":[68],"48":[71],"more":[72],"weeks;":[73],"sham-treated":[74],"continued":[76],"sham,":[77],"discontinued":[78],"received":[80],"pegaptanib.":[81],"At":[82],"102":[83],"weeks,":[84],"receiving":[86,100],"0.3":[88,118],"mg":[89,92,103,119,122],"2":[97,114],"continued;":[98],"those":[99],"who":[105],"did":[106],"not":[107],"year":[124,138,171],"3.":[125,139,172],"RESULTS:":[126],"As":[127],"2,":[132],"was":[134,199],"well":[135],"tolerated":[136],"Adverse":[140],"events":[141,153],"mainly":[143],"ocular":[144],"nature,":[146],"mild,":[147],"transient":[148],"injection-related.":[150],"Serious":[151],"adverse":[152],"rare.":[155],"No":[156],"evidence":[157],"systemic":[159],"signals":[161],"attributed":[162],"vascular":[164],"endothelial":[165],"growth":[166],"factor":[167],"inhibition":[168],"arose":[169],"There":[173],"no":[175],"findings":[176],"relation":[178],"vital":[180],"signs":[181],"electrocardiogram":[183],"results":[184],"suggesting":[185],"a":[186],"relationship":[187],"treatment.":[190],"CONCLUSION:":[191],"The":[192],"3-year":[193],"profile":[195],"favourable":[200],"patients":[202],"NV-AMD.":[204]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2108364254","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":19},{"year":2013,"cited_by_count":18},{"year":2012,"cited_by_count":14}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
